Ciaffoni Joseph's Form 4 filing
Collegium Pharmaceutical, Inc (COLL) · filed Dec 22, 2023
- Accession no.
- 0001062993-23-023100
- Filed
- Dec 22, 2023
- Trade date
- Dec 21, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 1 derivative transaction. Open-market sales total $132.4K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Ciaffoni JosephCIK 0001443841 | Director, Officer (President and CEO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Common Stock | MOption exerciseAcquired | +4,357 | $21.34 | +$92,978.38 | 279,357 | Direct | |
| Dec 21, 2023 | Common Stock | SSaleDisposed | −4,357 | $30.38 | −$132,365.66 | 275,000 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Dec 21, 2023 | Common Stock | MOption exerciseDisposed | −4,357 | $0.00 | $0 | 16,875 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.